Global Digital Diagnostics Market Size (2024 - 2029)

The digital diagnostics market is anticipated to experience substantial growth, driven by the increasing adoption of technology for chronic disease management and the rising demand for innovative diagnostic solutions, particularly for cardiovascular diseases. The expansion of COVID-19 testing beyond traditional settings has further accelerated the need for automated and harmonized diagnostic data sharing. Additionally, the launch of new products and services by key market players is expected to contribute to the market's expansion. However, the high cost of diagnostic instruments may pose a challenge to market growth.

Market Size of Global Digital Diagnostics Industry

digital diagnostics market
Study Period 2019 - 2029
Market Size (2024) USD 1.19 Billion
Market Size (2029) USD 2.72 Billion
CAGR (2024 - 2029) 18.08 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

Digital Diagnostics Market Analysis

The Global Digital Diagnostics Market size is estimated at USD 1.19 billion in 2024, and is expected to reach USD 2.72 billion by 2029, growing at a CAGR of 18.08% during the forecast period (2024-2029).

As COVID-19 diagnostic testing becomes more widespread and accessible beyond laboratories at points of care, at schools and workplaces, at home, and over-the-counter, it is essential that diagnostic data from testing devices are harmonized, automated, and shared with medical providers and reported to appropriate public health authorities. The COVID-19 TOPx Tech Sprint is one of the many innovative approaches we are exploring to accelerate the development of digital tools to accurately capture, harmonize, and report SARS-CoV-2 diagnostic testing data. The article 'COVID-19 TOPx Tech Sprint Final Demos: Showcasing Digital Diagnostic Tools,' published in April 2021, stated that the National Institute of Health, in collaboration with the Center for Disease Control and Prevention, launched the 'Say Yes! COVID Test' community health initiative, an innovative approach to ensure that accurate COVID-19 tracking data is captured through regular screening with at-home COVID-19 tests to strengthen prevention efforts. Thus, the adoption of technology to track COVID-19 will have a significant impact on the market growth.

The factors propelling the studied market growth are the growing burden of chronic diseases such as cardiac diseases, neurological diseases, cancer, and others, adoption of technology for chronic disease management, rising investments, increasing product and service launches, and adoption of key strategies by major market players.

According to a study published by the British Heart Foundation in January 2022, there were approximately 7.6 million people with heart disease in the United Kingdom and nearly 160,000 deaths each year. An average of 460 fatalities each day or one death every three minutes happen in the United Kingdom due to cardiovascular disorders (CVDs). Due to the rising burden of cardiovascular diseases, there is an increasing demand for innovative technologies diagnosing cardiovascular diseases, thereby driving the digital diagnostics market.

Additionally, the launch of new products and services is expected to boost the market growth globally. For instance, in February 2022, Carestream Health India launched the DRX Compass, an accurate, convenient & configurable digital radiology solution designed to provide radiologists with a whole new level of efficiency. It offers the versatility to build the desired configuration from a wide range of selections in detectors, tubes, generators, tables, and collimators, giving Radiology facilities full control over how they can use this future-proof digital radiology technology.

Furthermore, In January 2021, Roche launched its automated digital pathology algorithms, uPath HER2 (4B5) image analysis, and uPath HER2 Dual ISH image analysis for breast cancer to help determine the best treatment strategy for each patient.

Therefore, owing to the aforementioned factors, the studied market is expected to grow significantly during the study period. However, the high cost of instruments is expected to hinder the market growth during the study period.

Digital Diagnostics Industry Segmentation

As per the scope of the report, the integration of digital technology such as Artificial Intelligence for the diagnosis of chronic diseases, such as cardiac diseases, neurological disorders, and others, is defined as the application of information processing involving both computer hardware and software that deals with the storage, retrieval, sharing, and use of healthcare information, data, and knowledge for communication and decision-making. The Digital Diagnostics Market is Segmented by Product (Hardware, Software, and Services), by Diagnosis Type (Cardiology, Oncology, Neurology, Radiology, Pathology, and Others), by End User (Hospitals and Clinics, Clinical Laboratories, and Others) and by Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product
Hardware
Software
Services
By Diagnosis Type
Cardiology
Oncology
Neurology
Radiology
Pathology
Others
By End User
Hospitals and Clinics
Clinical Laboratories
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Digital Diagnostics Market Size Summary

The digital diagnostics market is poised for substantial growth, driven by the increasing integration of technology in healthcare settings and the rising prevalence of chronic diseases such as cardiovascular conditions and cancer. The market is experiencing a surge in demand due to the need for innovative diagnostic solutions that can efficiently manage and track these health issues. The COVID-19 pandemic has further accelerated this trend, as the need for widespread and accessible testing has highlighted the importance of digital tools in capturing and reporting diagnostic data. Initiatives like the COVID-19 TOPx Tech Sprint and community health programs have underscored the critical role of digital diagnostics in public health, fostering advancements in technology that are expected to have a lasting impact on the market.

In addition to the technological advancements, the market is witnessing a flurry of new product launches and strategic partnerships among key players, which are contributing to its dynamic growth. Companies such as Carestream Health, Roche, and Hologic are at the forefront, introducing innovative solutions that enhance diagnostic accuracy and efficiency. The oncology segment, in particular, is benefiting from the high demand for early cancer detection and the development of digital platforms for cancer screening. North America, with its robust healthcare infrastructure and significant investment in digital health technologies, is expected to lead the market growth. However, challenges such as the high cost of diagnostic instruments may pose hurdles to market expansion. Despite these challenges, the market remains competitive and fragmented, with major players actively engaging in mergers, acquisitions, and partnerships to strengthen their market positions and drive further innovation.

Explore More

Global Digital Diagnostics Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Adoption of Digitalization in Chronic Disease Management

      2. 1.2.2 Increasing Burden of Chronic Diseases

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Instruments

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - in USD Million)

    1. 2.1 By Product

      1. 2.1.1 Hardware

      2. 2.1.2 Software

      3. 2.1.3 Services

    2. 2.2 By Diagnosis Type

      1. 2.2.1 Cardiology

      2. 2.2.2 Oncology

      3. 2.2.3 Neurology

      4. 2.2.4 Radiology

      5. 2.2.5 Pathology

      6. 2.2.6 Others

    3. 2.3 By End User

      1. 2.3.1 Hospitals and Clinics

      2. 2.3.2 Clinical Laboratories

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle-East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle-East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Digital Diagnostics Market Size FAQs

The Global Digital Diagnostics Market size is expected to reach USD 1.19 billion in 2024 and grow at a CAGR of 18.08% to reach USD 2.72 billion by 2029.

In 2024, the Global Digital Diagnostics Market size is expected to reach USD 1.19 billion.

Digital Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)